1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. SI-BONE, Inc.
  6. Company
    SIBN   US8257041090

SI-BONE, INC.

(SIBN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo SI-BONE, Inc.
SI-BONE, Inc. is a medical device company. The Company is focused on the development of implantable devices used in the surgical treatment of sacro-pelvic anatomy. Its invasive surgical implant system, iFuse, is used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. Its iFuse Implant System includes a series of triangular titanium implants and the instruments developed to enable surgeons to perform the procedure. Its iFuse system, which includes its implants and instruments, is designed to address the shortcomings of alternative treatments, including open surgery, non-surgical management, and screw-based and other minimally invasive stabilization and fusion procedures. Its iFuse-3D design allows the surgeons to fill the implant with ground-up bone before implantation, which accelerates bone through-growth and biological fixation. It also provides other technologies for its surgeons other than iFuse and iFuse-3D.

Number of employees : 352 people.
Sales per Business
20202021Delta
Surgical Implant System73.39100%90.15100% +22.84%
USD in Million
Sales per region
20202021Delta
United States68.1292.8%82.7491.8% +21.46%
International5.277.2%7.418.2% +40.69%
USD in Million
Managers
Name Title Age Since
Laura A. Francis Chief Executive Officer & Director 54 2021
Anshul Maheshwari Chief Financial & Accounting Officer 41 2021
Scott A. Yerby, Dr. Chief Technology Officer & Senior VP-Engineering 53 2011
W. Carlton Reckling, Dr. Vice President-Medical Affairs 59 2012
Michael A. Pisetsky Secretary, Chief Legal Officer & SVP-Operations 43 -
Matt Bacso Investor Contact - -
Joseph W. Powers Senior Director-Business Development 62 2011
Troy S. Wahlenmaier Director-Western Area Sales - 2014
Andrea Mercanti Vice President-EMEA Operations - 2013
Anthony J. Recupero President-Commercial Operations 62 2021
Members of the board
Name Title Age Since
Jeffrey W. Dunn Executive Chairman 66 2021
Gregory Hinckley Independent Director 74 2011
John Gordon Freund, Dr. Independent Director 67 2013
Timothy E. Davis Lead Independent Director 51 -
Keith C. Valentine Independent Director 53 2015
Jeryl Lynn Hilleman Independent Director 63 2019
Mika Nishimura Independent Director 57 2021
Helen Loh Independent Director 58 2021
Laura A. Francis Chief Executive Officer & Director 54 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 33,913,049 33,310,677 98.2% 0 0.0% 98.2%
Shareholders
NameEquities%
OrbiMed Advisors Private Equity 2,305,300 6.81%
Champlain Investment Partners LLC 1,970,385 5.82%
Arboretum Ventures, Inc. 1,547,400 4.57%
The Vanguard Group, Inc. 1,480,120 4.37%
RTW Investments LP 1,269,194 3.75%
Holocene Advisors, LP 1,221,209 3.61%
Gilder, Gagnon, Howe & Co. LLC 1,218,875 3.60%
Loomis, Sayles & Co. LP 1,164,188 3.44%
SSgA Funds Management, Inc. 988,626 2.92%
Avidity Partners Management LP 987,400 2.92%
Company contact information
SI-BONE, Inc.
471 El Camino Real
Suite 101
Santa Clara, CA 95050

Phone : +1.408.207.0700
Fax : +1.408.557.8312
Web : http://www.si-bone.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of SI-BONE, Inc.